Login / Signup
The prevalence of post-NDA drug patents and their relationship to the timing of generic approval.
Jonathan J Darrow
Victor Van de Wiele
Beatrice Brown
Aaron S Kesselheim
Published in:
Nature biotechnology (2024)
Keyphrases
</>
risk factors
drug administration
adverse drug